Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2010
04/15/2010US20100093751 Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor
04/15/2010US20100093748 Substituted piperidines having protein kinase inhibiting activity
04/15/2010US20100093738 Fungicidal Compounds and Fungicidal Compositions
04/15/2010US20100093733 Amide and urea derivatives for the treatment of metabolic diseases
04/15/2010US20100093727 Compounds and methods of use
04/15/2010US20100093724 Azaindazole Compounds As CCR1 Receptor Antagonists
04/15/2010US20100093718 Compounds
04/15/2010US20100093713 Beta-carbolines useful for treating inflammatory disease
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093705 Therapeutic agents, and methods of making and using the same
04/15/2010US20100093698 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
04/15/2010US20100093697 Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists
04/15/2010US20100093696 2-amino pyrimidine compounds
04/15/2010US20100092887 FLUORINE-CONTAINING QUINACRIDONES IN COLOUR FILTERS FOR LCDs
04/15/2010US20100092387 Novel Compound Having Affinity For Amyloid
04/15/2010US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives
04/15/2010CA2740035A1 Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs
04/15/2010CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010CA2739373A1 Tricyclic oxazolidinone antibiotic compounds
04/15/2010CA2739342A1 Oxazolidinyl antibiotics
04/15/2010CA2738870A1 Pyrrolidine n-benzyl derivatives
04/14/2010EP2174940A1 Process for production of optically active mirtazapine
04/14/2010EP2174934A1 Oxopyrazine derivative and herbicide
04/14/2010EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof
04/14/2010EP2173750A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
04/14/2010EP2173749A1 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents
04/14/2010EP2173748A2 Indolyl pyrrolidines for the treatment of cancer
04/14/2010EP2173747A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
04/14/2010EP2173721A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
04/14/2010EP2173717A2 Novel glucokinase activators and methods of using same
04/14/2010EP2173716A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
04/14/2010EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors
04/14/2010EP2173352A2 Inhibitors of akt/pkb with anti-tumor activity
04/14/2010EP2173346A2 Use of compounds for preparing anti-tuberculosis agents
04/14/2010EP1910357B1 Indoli zine derivatives and their use as crth2 antagonists
04/14/2010EP1796678B1 Carboxamide spirolactam cgrp receptor antagonists
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010CN101693714A spirocyclic cyclohexane derivatives
04/14/2010CN101693712A Method for synthesizing Varenicline intermediate 2, 3, 4, 5-tetralin-1, 5-methylene-hydrogen-benzoazepine
04/14/2010CN101205229B Dizotetracarboxylic dianiline compositions and preparation thereof
04/13/2010US7696229 Compounds having 5-HT6 receptor affinity
04/13/2010US7696225 (2-carboxamido)(3-Amino) thiophene compounds
04/13/2010US7696224 Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases
04/13/2010US7696223 Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof
04/13/2010US7696213 2-amino-8-(trans-4-hydroxycyclohexyl)-4-methyl-7-oxo-N-1H-pyrazol-5-yl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide; anticarcinogenic; phosphoinositide 3-kinase alpha (PI3-K alpha ) inhibitor; cell cycle regulation, proliferation, apoptosis; inhibit resistance to cytotoxic agents in cancer cells
04/13/2010US7696195 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
04/13/2010US7696194 Visual function disorder improving agents
04/13/2010US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders
04/13/2010CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2430363C Compounds and their uses
04/13/2010CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
04/08/2010WO2010039947A1 Novel compounds as calcium channel blockers
04/08/2010WO2010039851A1 Peripheral opioid receptor antagonists and uses thereof
04/08/2010WO2010039740A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα AND MTOR
04/08/2010WO2010039215A1 Berberine compounds and processes for the preparation of berberine compounds
04/08/2010WO2010038803A1 2-indoleacrylamide analogue
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2010038435A1 Method for producing hexahydropyrroloquinoline
04/08/2010WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process
04/08/2010WO2010038200A1 Oxazolidine compounds as orexin receptor antagonists
04/08/2010WO2010038165A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
04/08/2010WO2010038115A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
04/08/2010WO2010038081A2 Heterocyclic derivatives and methods of use thereof
04/08/2010WO2010038060A1 Heterocyclic jak kinase inhibitors
04/08/2010WO2010037765A2 4-morpholino-pyrido[3,2-d]pyrimidines
04/08/2010WO2010037249A1 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, their preparation methods, compositions and use
04/08/2010WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/08/2010US20100087649 Quinolinone derivatives
04/08/2010US20100087648 Novel nitrogen-containing heterocyclic compounds, their preparation and their use as antibacterial drugs
04/08/2010US20100087477 Selective glycosidase inhibitors
04/08/2010US20100087471 Indole and indoline derivatives and methods of use thereof
04/08/2010US20100087456 PYRIDOPYRIMIDINONE INHIBITORS OF PI3K-ALPHA and mTOR
04/08/2010US20100087450 Organic compounds
04/08/2010US20100087440 Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use
04/08/2010US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents
04/08/2010US20100087320 Arylphenyl-substituted cyclic keto-enols
04/08/2010CA2742550A1 4-morpholino-pyrido[3,2-d]pyrimidines
04/08/2010CA2739503A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/08/2010CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010CA2737480A1 Novel compounds as calcium channel blockers
04/08/2010CA2737217A1 Heterocyclic jak kinase inhibitors
04/08/2010CA2735932A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
04/07/2010EP2172469A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
04/07/2010EP2172444A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
04/07/2010EP2171028A1 Biheteroaryl metal complexes as bleach catalysts
04/07/2010EP2170886A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors
04/07/2010EP2170885A1 Beta-carboline arylsulfonamides, method for preparing them and composition comprising them
04/07/2010EP2170884A2 Chemical compounds
04/07/2010EP2170883A1 Substituted fused pyrimidines as antagonists of gpr105 activity
04/07/2010EP2170882A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
04/07/2010EP2170881A1 Crystalline pyridazine compound
04/07/2010EP2170880A2 A process for the preparation of intermediates of tetracyclic compounds
04/07/2010EP2170879A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors